Orphan Drugs To Make Up 16% Of Rx Market By 2018, Says Evaluate Pharma

By Lisa LaMotta / Email the Author / Apr. 23, 2013 

Word Count: 845 / Article # 14130423002 / Posted: April 23 2013 3:25 PM

---

Executive Summary

The health care consultancy released a report that shows the rapid growth of the orphan drug sector as companies take advantage of incentives. Orphan oncologic drugs dominate the market, and Novartis is slated to lead in orphan sales by 2018.

read article By Lisa LaMotta / Email the Author / Apr. 23, 2013 Word Count: 845 / Article # 14130423002 / Posted: April 23 2013 3:25 PM Executive Summary The health care consultancy released a report that shows the rapid growth of the orphan drug sector as companies take advantage of incentives. Orphan oncologic drugs dominate the market, and Novartis is slated to lead in orphan sales by 2018.